Last reviewed · How we verify

NCT06759116

Comparison Between Fentanyl and Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block for Postoperative Analgesia After Knee Surgeries

Recruiting now NA Last updated 14 January 2025
What this trial tests

NA trial testing Control group in Analgesia, Postoperative in 111 participants. Currently enrolling.

Timeline
10 January 2025
Primary endpoint
10 July 2025
10 August 2025

Quick facts

Lead sponsorZagazig University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment111
Start date10 January 2025
Primary completion10 July 2025
Estimated completion10 August 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 21 to 85, any sex, with Analgesia, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be undertaken to compare the analgesic effects of of fentanyl versus dexmedetomidine as adjuvant to bupivacaine in combined IPACK and ACB for pain management after total knee arthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Control group

Trials testing the same drug.

Other recruiting trials for Analgesia, Postoperative

Currently open trials in the same condition.

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06759116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing